Qiagen NV (NYSE:QGEN)
| 47.52 Delayed Data As of Mar 05 |  -0.06 / -0.13%Today’s Change | 36.16 Today|||52-Week Range 59.00 | -10.09% Year-to-Date |
Latest QGEN News | Press Releases
| QIAGEN (QGEN) Unveils Digital Platform for Syndromic Testing Mar 05 / Zacks.com - Paid Partner Content | QIAGEN (QGEN) Launches QIAcube Connect MDx Platform Globally Mar 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 47.58 |
| Today’s open | 47.11 |
| Day’s range | 46.54 - 47.74 |
| Volume | 693,709 |
| Average volume (3 months) | 917,210 |
| Market cap | $11.0B |
Data as of 4:00pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +16.10% |
| Earnings growth (next 5 years) | +11.40% |
| Revenue growth (last year) | +22.53% |
| P/E ratio | 57.3 |
| Price/Sales | 6.62 |
| Price/Book | 3.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | +0.75 | +1.28% |
| PKIPerkinElmer Inc | -0.20 | -0.16% |
| BIOBio Rad Laboratories... | +6.68 | +1.19% |
| PACBPacific Biosciences ... | +0.59 | +2.05% |
Data as of 4:46pm ET, 03/05/2021
Financials
| Next reporting date | May 5, 2021 |
| EPS forecast (this quarter) | $0.63 |
| Annual revenue (last year) | $1.9B |
| Annual profit (last year) | $359.2M |
| Net profit margin | 19.20% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
